Post Profile






Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

(Reuters) - State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China drug distribution business for $557 million, as it seeks to expand its distribution and retail network nationwide.
read more

share

Related Posts


Cardinal settles with U.S. over painkiller shipments to pharmacies

Health : Reuters: Health

NEW YORK (Reuters) - A drug distributor owned by Cardinal Health Inc has agreed to pay $10 million to resolve claims it failed to alert the U.S. Drug Enforcement Administration to suspiciously large orders of addictive painkillers b...

Cardinal Health Inc., Agrees To Pay $34 Million To Settle Claims That It Failed To Report Suspicious Sales Of Widely-Abused Controlled Substance

Health : Medical News Today

Cardinal Health Inc., one of the nation's largest distributors of pharmaceutical drugs, has agreed to settle allegations that it violated federal reporting provisions relating to its handling of certain controlled substances regulat...

Fosun agrees to buy KKR-backed Indian drug maker for $1.4 billion: source

Business & Finance : Business Insider: Clusterstock

HONG KONG (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma - which is backed by KKR & Co LP - for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound...

Shanghai Pharma bids for U.S. Cardinal Health's China business

Health : Reuters: Health

HONG KONG (Reuters) - Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc's China business as the U.S. company looks to sell ahead of China's planned drug distribution reform.

Shanghai Pharma says bid for U.S. Cardinal Health's China business

Health : Reuters: Health

HONG KONG (Reuters) - Shanghai Pharmaceuticals Holding Co said it has bid for Cardinal Health Inc's China business, as the U.S. drug distributor looks to exit over worries China's upcoming drug distribution reform could slow its gro...

Comments


Copyright © 2016 Regator, LLC